Fecal carriage of extended-spectrum β-lactamase and carbapenemase-producing enterobacterales strains in patients with colorectal cancer in the oncology unit of …

A Touati, M Talbi, A Mairi, A Messis… - Microbial Drug …, 2020 - liebertpub.com
Background: The prevalence of extended-spectrum β-lactamase (ESBL)-producing
Enterobacterales (ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now …
被引用次数：4 相关文章

Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit …

A Touati, M Talbi, A Mairi, A Messis… - Microbial Drug …, 2020 - europepmc.org
Background: The prevalence of extended-spectrum β-lactamase (ESBL)-producing
Enterobacterales (ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now …

Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit …

A Touati, M Talbi, A Mairi, A Messis… - Microbial Drug …, 2020 - hal.umontpellier.fr
The prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales
(ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now disseminated …

Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit …

A Touati, M Talbi, A Mairi, A Messis, A Adjebli… - Microbial Drug …, 2020 - hal.science
The prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales
(ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now disseminated …

Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit …

A Touati, M Talbi, A Mairi, A Messis… - Microbial drug …, 2020 - pubmed.ncbi.nlm.nih.gov
Background: The prevalence of extended-spectrum β-lactamase (ESBL)-producing
Enterobacterales (ESBL-E) and carbapenemase-producing Enterobacterales (CPE) is now …